SFS
LAB icon

Sowell Financial Services’s Standard BioTools LAB Stock Holding History

Sowell Financial Services’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-400
Closed -$3K – 2781
2020
Q3 		$3K Buy
+400
New +$2.76K ﹤0.01% 2131

Other funds holding LAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

Sowell Financial Services's LAB Position: Q4 2020 in Review

Sowell Financial Services sold out of Standard BioTools (LAB) in Q4 2020, closing a stake of 400 shares — an estimated $3K sold.

Sowell Financial Services first reported a position in LAB in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 145 funds tracked by Wall St. Rank hold LAB as of Q4 2020.

  • Sowell Financial Services reported no remaining Standard BioTools position as of Q4 2020 after selling out during the quarter.
  • Sowell Financial Services sold 400 Standard BioTools shares in Q4 2020, an estimated $3K.
  • Sowell Financial Services first reported a position in Standard BioTools in Q3 2020 and held it in 1 quarter.
  • Sowell Financial Services's Standard BioTools position peaked at $3K in Q3 2020.
  • 145 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2020.

Based on Sowell Financial Services's 13F filing for Q4 2020, filed 13 Jan 2021.